Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Using liposomal bupivacaine for pain relief after lung surgery

Official title: Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial

Run by The Second Affiliated Hospital of Chongqing Medical University · NCT06569953 · Data updated 2026-11-12

This study is testing whether a new form of pain relief called liposomal bupivacaine can help people manage pain better after lung surgery compared to the standard treatment.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment284 (estimated)
SponsorThe Second Affiliated Hospital of Chongqing Medical University
Academic / other
Locations1 site (Chongqing, Chongqing Municipality)
StatusRecruiting
StartedAugust 26, 2024
Main results expectedAugust 31, 2025
Study endsAugust 31, 2025
Registry record updatedJune 27, 2025
Trial IDNCT06569953 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older scheduled for elective video-assisted thoracoscopic lobectomy.

Probably not a fit

Patients with severe cardiovascular or cerebrovascular diseases, psychiatric disorders, or other significant pain conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the efficacy and safety of liposomal bupivacaine administered via paravertebral block for managing acute and chronic pain following video-assisted thoracoscopic lobectomy. Participants will receive either liposomal bupivacaine or standard bupivacaine before surgery and will track their pain levels at various intervals post-surgery. The study is designed as a multicenter, randomized, double-blind, controlled trial to ensure robust results.

Why it matters

Potential benefit: If successful, this treatment could provide more effective pain management for patients undergoing lung surgery.

How similar studies have gone: Other studies have shown promise with liposomal formulations for pain management, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants who scheduled for elective video-assisted thoracoscopic lobectomy under general anesthesia.
* Participants were 18 years or older.
* 18 kg/m2≤BMI≤30 kg/m2
* Participants with American Society of Anesthesiology (ASA) physical status I-III.
* Understand the significance, possible benefits, potential risks of the trial in detail.Understand the procedures and methods of this study.Willing to complete the trial in strict compliance with the clinical trial protocol.Sign the informed consent form voluntarily.

Exclusion Criteria:

* with severe cardiovascular and cerebrovascular diseases such as myocardial infarction,unstable angina pectoris,severe cardiac rhythm disorders (second- and third-degree heart block,etc.), New York Heart Association (NYHA) functional class III/IV,Ischemic stroke.
* with psychiatric disorders (such as schizophrenia,depression,etc.) and cognitive impairment.
* with sensory disorders such as hyperalgesia.
* with other bodily pain.
* allergy to amide-type local anesthetics or any of the trial drugs
* taking drugs that affect liver metabolism,corticosteroids,benzodiazepines,non-steroidal anti-inflammatory drugs(NSAIDs),opioid agonist-antagonist,central-alpha 2-agonists,anticonvulsants,antidepressants within 72h.
* with a history of alcohol or opioid abuse.
* who were pregnant or lactating.
* who were currently included in another clinical study within 3 months.

Where it's running

  • The Second Affiliated Hospital of Chongqing Medical University
    Chongqing, Chongqing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.